Researchers from Imperial College London and colleagues have found a potential way to target the receptors that specifically control appetite in mice, potentially without causing other side effects.
Thyroid hormone receptors (TRs) are spread widely throughout the body and interact with circulating thyroid hormones to regulate functions such as appetite, the nervous system, body temperature, and cholesterol levels. Thus, any drug targeting thyroid hormones and their receptors needs to be specific to avoid affecting other body systems.
Our hope is that these findings could ultimately lead towards drugs that target thyroid hormones as a way to reduce someone’s appetite and help them control their weight.
– Dr James Gardiner
Department of Medicine
However, they are TRs are difficult to target individually due to their high numbers and so there are currently no anti obesity drugs that target them.
Now, researchers from Imperial and colleagues have found a potential way to target specific TRs located only in the hypothalamus, an area of the brain that regulates appetite. The authors say the findings might lead to developing a new type anti-obesity drug in the future.
Dr James Gardiner, lead author of the research from Imperial’s Department of Medicine, said: “Our hope is that these findings could ultimately lead towards drugs that target thyroid hormones to reduce someone’s appetite and help them control their weight. We haven’t been able to target these hormones before without lots of side effects, but in this study we’ve been able to be very specific about which hormones we’re targeting, which should greatly lessen potential side effects in humans. We are excited to see where this might lead in the future fight against obesity.”
In this early stage research, the authors divided 21 mice, who weighed roughly 20g each, into two groups. They injected mice in the first group with viruses that inactivated the brain TRs, but did not inject the second group. They then let both groups eat as much as they chose. Afterwards, the researchers examined the brains of the mice to confirm the virus had in fact inactivated the targeted receptors.
Any potential treatment that could result from this will be far off in the future. However, the strength of our results, and the doubling in body size of these mice, shows there’s that the role of thyroid hormones and their receptors are definitely worth exploring further in the fight against obesity.
– Dr Gardiner
Department of Medicine
They found that the group of mice with the inactive TRs ate much more food and doubled in weight on average, from the baseline of 20 grams to 40 grams over six weeks. The mice with active TRs maintained a stable body weight of 20 grams.
The authors say this is evidence that when targeting drugs to a specific, local, receptor in the correct brain area, they can alter appetite in these mice without causing other side effects. This could potentially help humans in the future, where a drug might decrease a person’s appetite by activating TRs in the hypothalamus, without causing effects in other parts of the body. Dr Gardiner said: “If our findings can be applied to humans, then we may have a new target for obesity medication.”
Humans with lowered TR activity in their brains have previously been found to be more obese on average than others. If this research continues into testing drugs on human subjects, there would be no simple test to measure levels of TR activity and adjust medication accordingly. Rather, treatment would be based on a system of trial and error with regard to whether the drug worked for specific individuals.
However, the authors warned that this research is at an early stage and that the results should be taken with caution. Dr Gardiner added: “Due to the justifiably long and complex process of drug discovery, any potential treatment that could result from this will be far off in the future. However, the strength of our results, and the doubling in body size of these mice, shows there’s that the role of thyroid hormones and their receptors are definitely worth exploring further in the fight against obesity.”
The Latest on: Appetite control
- How the pandemic could save uson June 19, 2021 at 5:27 pm
Despite the tragic deaths, suffering and sadness that it has caused, the pandemic could go down in history as the event that rescued humanity. This column argues that the pandemic has created a hinge ...
- USD/JPY dips but dollar bulls remain in controlon June 17, 2021 at 3:24 pm
With that said, USD/JPY fell from its highs after U.S. data. Other major currencies quietly trickled lower versus the greenback. The dollar maintained its bid because the Federal Reserve gave bulls ...
- Nadal’s unexpected holiday shows the stars are taking back controlon June 17, 2021 at 3:10 pm
Rafael Nadal casually put it out there that he’s taking the summer off. He’ll be skipping Wimbledon and the Tokyo Olympics. “It’s never an easy decision to take but after listening to my body and ...
- Incretin drugs for glycaemic controlon June 17, 2021 at 11:34 am
Over the past 15 years, drugs targeting the incretin hormones (Milestone 9), including glucagon-like peptide 1 (GLP1), have emerged as effective anti-hyperglycaemic agents. GLP1 is produced in the ...
- Putin and Biden agree at summit to resume arms control talkson June 16, 2021 at 1:00 pm
President Joe Biden and Russian President Putin agreed at their first summit on Wednesday to resume arms control talks and to return ambassadors to each other’s capitals ...
- Biden, Putin summit tackle cyber-security, arms control issueson June 16, 2021 at 10:58 am
US President Joe Biden and Russian President Vladimir Putin decided at a "pragmatic" first summit on Wednesday to hold arms control and cyber-security talks and return their respective ambassadors, ...
- US, Russia to resume arms control talkson June 16, 2021 at 8:39 am
US President Joe Biden and Russian President Vladimir Putin have agreed at their first summit to resume arms control talks and to return ambassadors to each ...
- USD/JPY Forecast: Bulls retain control despite trading below 110.00on June 16, 2021 at 4:27 am
USD/JPY is technically bullish, but traders wait for the Fed. The greenback is under mild selling pressure this Wednesday, although trading remains choppy ahead of the US Federal Reserve’s ...
- CBDCs: Authorities bank on digital currencies to take back control from cryptoon June 15, 2021 at 6:08 am
CBDCs are on the rise, as regulators fight back against decentralised finance. But as leading economists from Globesec argue, they're a solution in search of a problem.
- SA to regulate crypto trade in phased manner to curb fraud, control cross-border flowon June 14, 2021 at 6:38 am
"In Jan, daily value of crypto-asset trading exceeded R2bn for first time in SA, in a market largely going unchecked by regulatory powers." ...
via Google News and Bing News